FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Clinical trial NCT05069935 · TERMINATED
Trial details
- NCT number
- NCT05069935
- Sponsor
- Fate Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-15
- Primary completion
- 2023-08-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.